Bromide

Bromide

SCHEMBL574336

CCCCCC[n+]1ccn(Cc2ccccc2)c1.[Br-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.47
CHRM4 known ✓ P08173 1/20 0.47
CHRM5 known ✓ P08912 1/20 0.47
CHRM1 known ✓ P11229 1/20 0.47
CHRM3 known ✓ P20309 1/20 0.47
ACHE known ✓ P22303 1/20 0.47
HSP90AA1 P07900 2/20 0.47
RAD52 P43351 2/20 0.47
EGFR P00533 1/20 0.47
LMNA P02545 1/20 0.47
PLA2G1B P04054 1/20 0.47
ERBB2 P04626 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
ADRA2A P08913 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
TSHR P16473 1/20 0.47
ALOX12 P18054 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL21293916 1.00 HSP90AA1 (0.47) HSP90AA1RAD52EGFRLMNAPLA2G1B
Bromide SCHEMBL16445313 1.00 HSP90AA1 (0.47) HSP90AA1RAD52EGFRLMNAPLA2G1B
SCHEMBL5304009 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5301214 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5817318 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5295433 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5295972 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5813633 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5298450 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5302619 0.99 ABCB11 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9999217-B2 Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures BIOMATRICA, INC. (US) 2018-06-19 US claimed
EP-2598660-B1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA INC (US) 2017-03-15 EP claimed
US-20160338342-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2016-11-24 US claimed
US-9376709-B2 Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures BIOMATRICA, INC. (US) 2016-06-28 US claimed
EP-2598660-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES Biomatrica, INC. (US) 2013-06-05 EP claimed
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2012-03-01 US claimed
WO-2012018638-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA, INC. (US) 2012-02-09 WO claimed
US-20220032306-A1 CAPSULE CONTAINMENT OF DRIED REAGENTS TALIS BIOMEDICAL CORPORATION 2022-02-03 US disclosed
US-20210008559-A1 CAPSULE CONTAINMENT OF DRIED REAGENTS TALIS BIOMEDICAL CORPORATION 2021-01-14 US disclosed
US-10207269-B2 System and method for movement and timing control CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-02-19 US disclosed
EP-2839260-B1 FLUIDIC DEVICES AND SYSTEMS FOR SAMPLE PREPARATION OR AUTONOMOUS ANALYSIS TALIS BIOMEDICAL CORP (US) 2018-07-18 EP disclosed
US-9999217-B2 Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures BIOMATRICA, INC. (US) 2018-06-19 US disclosed
US-9822356-B2 Fluidic devices and systems for sample preparation or autonomous analysis CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-11-21 US disclosed
US-20130309679-A1 FLUIDIC DEVICES AND SYSTEMS FOR SAMPLE PREPARATION OR AUTONOMOUS ANALYSIS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2013-11-21 US disclosed
WO-2013159117-A1 FLUIDIC DEVICES AND SYSTEMS FOR SAMPLE PREPARATION OR AUTONOMOUS ANALYSIS SlipChip, LLC (US) 2013-10-24 WO disclosed
WO-2013159116-A1 FLUIDIC DEVICES FOR BIOSPECIMEN PRESERVATION UNIVERSITY OF CHICAGO (US) 2013-10-24 WO disclosed
US-20130280725-A1 FLUIDIC DEVICES FOR BIOSPECIMEN PRESERVATION CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2013-10-24 US disclosed
EP-2598660-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES Biomatrica, INC. (US) 2013-06-05 EP disclosed
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES EXACT SCIENCES CORPORATION 2012-03-01 US disclosed
WO-2012018638-A2 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES BIOMATRICA, INC. (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160338342-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES HNRNPD, HNRNPDL, HNRNPL CHRM2 4853/4885CHRM4 4858/4885CHRM5 4842/4885
US-20120052572-A1 COMPOSITIONS FOR STABILIZING DNA, RNA AND PROTEINS IN BLOOD AND OTHER BIOLOGICAL SAMPLES DURING SHIPPING AND STORAGE AT AMBIENT TEMPERATURES HNRNPD, HNRNPDL, HNRNPL CHRM2 4853/4885CHRM4 4858/4885CHRM5 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.